Two Phase 3 clinical trials testing Tyvaso (treprostinil) in people with idiopathic pulmonary fibrosis (IPF) both met their ...

As he navigates his rare disease journey, columnist Samuel Kirton feels it is his responsibility to be a "five-star patient." ...

Columnist Ann Reynoso says she can't get used to the chronic cough of PF, but she's working to overcome the fear and ...

Brainomix and Boehringer Ingelheim will advance testing of an AI-based analysis tool that may enable earlier diagnosis of PF.

Columnist Sam Kirton began taking Ozempic to manage his blood sugar and CKD, but losing weight has been a welcome secondary benefit.

Authorities in China have given a green light to an early clinical trial testing inhaled rentosertib for IPF in patients and volunteers.

Enrollment has finished ahead of schedule in a Phase 2 clinical trial testing Calluna Pharma‘s experimental antibody therapy CAL101 in people with idiopathic pulmonary fibrosis (IPF). The Phase 2 ...

A 24-hour news cycle, a lack of civil discourse, people who believe their needs are a priority, and the stress of a chronic, progressive disease with no cure: These things, and many more, contribute ...

Abnormalities in DNA methylation — a type of genetic modification that can alter the activity of a gene without changing its sequence — may affect a person’s risk of developing idiopathic pulmonary ...

Fast shallow breathing (tachypnea) is one of several breathing difficulties experienced by pulmonary fibrosis (PF) patients. Breathing problems are common in PF because the disease causes progressive ...